Status:
WITHDRAWN
Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
Lead Sponsor:
AstraZeneca
Conditions:
Venous Thrombosis
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study evaluates whether treatment with rosuvastatin on top of standard anti-coagulant treatment will decrease the risk of recurrent venous thromboembolism and arterial thromboembolic events in pa...
Eligibility Criteria
Inclusion
- Signed informed Consent.
- Patients with venous thromboembolism who are treated with anti-coagulant according to the current guidelines
Exclusion
- Patients in need of or already treated with lipid lowering drugs
- Active liver or kidney disease or dysfunction or muscle disorders
- Unstable medical or psychological condition that interferes with study participation
- Pregnant woman or woman with childbearing potential who are not willing to use contraception
- History of statin-related muscular pain, or hypersensitivity to statins
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2013
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01164540
Start Date
February 1 2011
End Date
March 1 2013
Last Update
December 10 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.